Can a patient with Polycystic Ovary Syndrome (PCOS) undergo hormone testing while having an Intrauterine Device (IUD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hormone Testing for PCOS with an IUD in Place

Yes, a patient with PCOS can undergo hormone testing while having an IUD, as the IUD does not interfere with serum hormone measurements or affect the accuracy of hormonal assays used to diagnose or monitor PCOS. 1

Why IUDs Don't Interfere with Hormone Testing

The intrauterine device sits within the endometrial cavity and does not prevent blood sampling or alter systemic hormone levels measured through venipuncture 1. Hormone testing for PCOS involves measuring serum levels of:

  • Testosterone (the most frequently abnormal marker in 70% of PCOS cases) 2
  • Androstenedione (elevated in 53% of PCOS patients) 2
  • LH and FSH (with LH/FSH ratio abnormal in only 41-44% of cases) 2
  • Sex hormone binding globulin (SHBG) (typically decreased in PCOS, especially with hyperinsulinemia) 3
  • Insulin and glucose tolerance testing (to assess insulin resistance) 4, 3

None of these blood-based hormone measurements are affected by the physical presence of an IUD 1.

Important Considerations for LNG-IUD Users

If the patient has a levonorgestrel-releasing IUD (LNG-IUD), be aware that this may cause minor local hormonal effects, but systemic hormone levels remain interpretable for PCOS diagnosis and monitoring 5. Studies show that:

  • LNG-IUS use for 24 months in PCOS patients does not result in significant changes in most clinical and metabolic variables 5
  • Testosterone, LH, FSH, and SHBG levels remain measurable and clinically meaningful even with LNG-IUD in place 5
  • The LNG-IUD may actually improve some metabolic parameters (reduced LDL and total cholesterol) without obscuring the underlying PCOS hormonal profile 5

Optimal Timing for Hormone Testing

Draw blood samples in the early follicular phase (days 2-5 of the menstrual cycle) if the patient still has menstrual bleeding 2. For patients with oligomenorrhea or amenorrhea (common in PCOS), testing can be performed at any time, but document the timing 2, 4.

Recommended Hormone Panel Priority

Based on diagnostic sensitivity, order these tests in priority:

  1. Total testosterone (best single hormonal marker with 70% sensitivity) 2
  2. Androstenedione (53% sensitivity) 2
  3. LH (35% sensitivity alone) 2
  4. SHBG (correlates with insulin resistance and body mass index) 2, 3
  5. Fasting insulin and glucose or oral glucose tolerance test (to assess metabolic dysfunction) 4, 3

The combination of testosterone, androstenedione, or LH (either alone or together) will identify 86% of PCOS cases 2.

Critical Pitfall to Avoid

Do not rely on LH/FSH ratio as a primary diagnostic criterion—it has poor sensitivity (only 41-44%) and should be abandoned as a standalone biochemical marker for PCOS 2. While the mean LH/FSH ratio is significantly elevated in PCOS populations, it fails to identify the majority of individual cases 2.

Copper IUD Considerations

Copper IUDs (Cu-IUD) have zero hormonal effects and pose absolutely no interference with hormone testing for PCOS 6. These devices are purely mechanical contraceptives and do not alter any endocrine measurements 6.

References

Guideline

Ultrasound Visualization of PCOS in Patients with an IUD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Which hormone tests for the diagnosis of polycystic ovary syndrome?

British journal of obstetrics and gynaecology, 1992

Research

Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2001

Research

Levonorgestrel-releasing intrauterine system effects on metabolic variables in PCOS.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.